Vasculitis Trial, Recruiting (NCT07558382)

Vasculitis Trial, Recruiting NCT07558382 Sponsor: Marmara University Condition: Vasculitis

Printed from Voxsanity (voxsanity.com.au) — NCT07558382 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vasculitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Takayasu arteritis, confirmed using recognised medical diagnostic guidelines (called ACR 1990 or ACR/EULAR 2021 criteria).
You (or your legal guardian/representative, if applicable) are willing and able to follow the study requirements for the full length of the trial.
You (or your legal guardian/representative) are willing to sign a written consent form after being fully informed about what the study involves, what it means, and any potential implications.
You (or your legal guardian/representative) understand and accept that you may leave the study at any time without it affecting your future medical care.
You (or your legal guardian/representative) agree to inform the research team of any medical events or changes in your health during the study.

Who may not be able to join:

You have not been formally diagnosed with Takayasu arteritis using the recognised diagnostic guidelines mentioned above (confirm with trial site).
You (or your legal guardian/representative) have not provided a signed consent form agreeing to take part in the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +902166574545

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07558382

Sponsor: Marmara University

Phase: Not Applicable

Status: Recruiting

Condition: Vasculitis

Trial contact: +902166574545

More information: https://clinicaltrials.gov/study/NCT07558382

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Takayasu arteritis, confirmed using recognised medical diagnostic guidelines (called ACR 1990 or ACR/EULAR 2021 criteria).
You (or your legal guardian/representative, if applicable) are willing and able to follow the study requirements for the full length of the trial.
You (or your legal guardian/representative) are willing to sign a written consent form after being fully informed about what the study involves, what it means, and any potential implications.
You (or your legal guardian/representative) understand and accept that you may leave the study at any time without it affecting your future medical care.
You (or your legal guardian/representative) agree to inform the research team of any medical events or changes in your health during the study.

Who may not be able to join:

You have not been formally diagnosed with Takayasu arteritis using the recognised diagnostic guidelines mentioned above (confirm with trial site).
You (or your legal guardian/representative) have not provided a signed consent form agreeing to take part in the study.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Marmara University

Registry

ClinicalTrials.gov

Start date

5 August 2025

Est. completion

1 August 2035

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Rate of Clinical Remission at 12 Months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov